| 1 | focus on your science | | | | | | | 2 | 0.35% |
| 2 | works with you to | | | | | | | 2 | 0.35% |
| 3 | molecular modeling and visualization | | | | | | | 2 | 0.35% |
| 4 | basis works with you | | | | | | | 2 | 0.35% |
| 5 | experiments basis works with | | | | | | | 1 | 0.17% |
| 6 | on hit or lead | | | | | | | 1 | 0.17% |
| 7 | can apply cheminformatics computational | | | | | | | 1 | 0.17% |
| 8 | basis can apply cheminformatics | | | | | | | 1 | 0.17% |
| 9 | optimization basis can apply | | | | | | | 1 | 0.17% |
| 10 | gathering managing and curating | | | | | | | 1 | 0.17% |
| 11 | managing and curating your | | | | | | | 1 | 0.17% |
| 12 | and curating your data | | | | | | | 1 | 0.17% |
| 13 | or lead selection and | | | | | | | 1 | 0.17% |
| 14 | hit or lead selection | | | | | | | 1 | 0.17% |
| 15 | insights and value from | | | | | | | 1 | 0.17% |
| 16 | and molecular modeling and | | | | | | | 1 | 0.17% |
| 17 | decisions on hit or | | | | | | | 1 | 0.17% |
| 18 | informed decisions on hit | | | | | | | 1 | 0.17% |
| 19 | enables informed decisions on | | | | | | | 1 | 0.17% |
| 20 | compounds enables informed decisions | | | | | | | 1 | 0.17% |
| 21 | and properties of your | | | | | | | 1 | 0.17% |
| 22 | activity and properties of | | | | | | | 1 | 0.17% |
| 23 | biological activity and properties | | | | | | | 1 | 0.17% |
| 24 | the biological activity and | | | | | | | 1 | 0.17% |
| 25 | and the biological activity | | | | | | | 1 | 0.17% |
| 26 | chemistry and molecular modeling | | | | | | | 1 | 0.17% |
| 27 | modeling and visualization methods | | | | | | | 1 | 0.17% |
| 28 | these relate to activity | | | | | | | 1 | 0.17% |
| 29 | and structural features of | | | | | | | 1 | 0.17% |
| 30 | how these relate to | | | | | | | 1 | 0.17% |
| 31 | and how these relate | | | | | | | 1 | 0.17% |
| 32 | series and how these | | | | | | | 1 | 0.17% |
| 33 | chemical series and how | | | | | | | 1 | 0.17% |
| 34 | with you to create | | | | | | | 1 | 0.17% |
| 35 | you to create and | | | | | | | 1 | 0.17% |
| 36 | to create and execute | | | | | | | 1 | 0.17% |
| 37 | structural features of your | | | | | | | 1 | 0.17% |
| 38 | pharmacophore and structural features | | | | | | | 1 | 0.17% |
| 39 | and visualization methods to | | | | | | | 1 | 0.17% |
| 40 | important pharmacophore and structural | | | | | | | 1 | 0.17% |